TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 41 filers reported holding TARSUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14,992 | -28.5% | 1,192,660 | -16.6% | 0.22% | -26.5% |
| Q4 2022 | $20,954 | -99.9% | 1,429,310 | -6.0% | 0.30% | -17.7% |
| Q3 2022 | $26,021,000 | +20.3% | 1,519,910 | +2.6% | 0.36% | +19.9% |
| Q2 2022 | $21,633,000 | +95.0% | 1,481,710 | +124.6% | 0.30% | +143.5% |
| Q1 2022 | $11,094,000 | -25.4% | 659,600 | -0.2% | 0.12% | -6.1% |
| Q4 2021 | $14,868,000 | +6.0% | 660,800 | +1.5% | 0.13% | +8.2% |
| Q3 2021 | $14,024,000 | -29.5% | 650,780 | -5.2% | 0.12% | -25.2% |
| Q2 2021 | $19,901,000 | +36.6% | 686,705 | +52.0% | 0.16% | +30.4% |
| Q1 2021 | $14,565,000 | -24.1% | 451,900 | -2.7% | 0.12% | -19.9% |
| Q4 2020 | $19,202,000 | – | 464,600 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |